PROGRAM

Moderator Profile

Time slot's time in Taipei (GMT+8)

Parallel Session III -2026/11/7

102

Genetics and Translational Pathways in Ataxia and Hyperkinetic Movement Disorders

  • Time
  • Topic
  • Speaker
  • Moderator
  • 14:00 - 14:30
  • Genetic Architecture of Hereditary Ataxia in Taiwan (TBC)
  • Speaker:  Yi-Chung Lee
  • Moderator:  Din-E Shan
(Taiwan)
  • Din-E  Shan
  • MD, PhD,
  • Visiting Staff on contract, Taipei Veterans General Hospital
    E-mail:deshan44@yahoo.com.tw
Executive Summary:
Professor Shan earned his MD from the National Taiwan University School of Medicine in 1980 and completed his PhD in Neuroscience at the University of Texas Medical Branch, Galveston, in 1990. He received residency training in Neurology at Taipei Veterans General Hospital, where he currently serves as Visiting Staff on contract. In 2002, he was appointed Professor of Neurology at the National Yang-Ming University School of Medicine, Taiwan. His research focuses on Parkinson’s disease and movement disorders. He has conducted pioneering studies on conditions more prevalent in Taiwan, including SCA2-related parkinsonism and hyperglycemia-induced hemichorea-hemiballism. His work has significantly advanced understanding of these disorders.

  • Time
  • Topic
  • Speaker
  • Moderator
  • 14:30 - 15:00
  • Pre-genetic testing and genetic diagnosis of patients with hyperkinetic disorders (TBC)
  • Speaker:  Gerard Saranza
  • Moderator:  Chin-Song Lu
(Taiwan)

  • Time
  • Topic
  • Speaker
  • Moderator
  • 15:00 - 15:30
  • From Observational Cohorts to Trials: Translational Pathways in Huntington’s Disease Research (TBC)
  • Speaker:  Klaus Seppi
  • Moderator:  Chiung-Mei Chen
(Taiwan)
  • Chiung-Mei  Chen
  • MD, PhD
  • Attending Physician, Department of Neurology, Chang Gung Memorial Hospital, Linkou, Taiwan.
    Professor, College of Medicine, Chang-Gung University, Taiwan
    E-mail:cmchen@adm.cgmh.org.tw
Executive Summary:
Dr. Chiung-Mei Chen graduated from Taipei Medical College in 1987. She received training in movement disorders in UCL Institute of Neurology, Queen Square, London, from 1994 to 1995 and obtained her Ph.D. degree in Molecular Genetics, University of Glasgow, U.K., 2002. She is currently a professor and physician scientist in Department of Neurology, Chang Gung Memorial Hospital, and College of Medicine, Chang-Gung University, Taoyuan, Taiwan. Dr. Chen’s main clinical and academic interests include Parkinson’s disease, spinocerebellar atrophy, Huntington’s disease, other movement disorders, neurogenetics, and neuroinflammatory diseases. She has already published more than 150 papers in SCI and several in renowned journals. Her main research is focusing on the pathogenesis, biomarkers, and therapeutics in polyglutamine diseases, Parkinson’s disease, Alzheimer's disease and also on neuroinflammation in neurological diseases. She is now the president of Society of Neurological Rare Disorders, Taiwan.

Back